Mode
Text Size
Log in / Sign up
N/A N=123 Randomized Treatment

Cervical Foley Plus Vaginal Misoprostol for Labor Induction

Induction of Labor

Enrolled (actual)
123
Serious AEs
Results posted
May 2019
Primary outcome: Primary: Time From Start of Labor Induction to Vaginal Delivery — 15.3; 18.3 hour — p=0.03

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Foley bulb (Device)
Age
Pediatric, Adult · 16+ yrs
Sex
Female
Sponsor
Washington University School of Medicine
Primary completion
Mar 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Time From Start of Labor Induction to Vaginal Delivery
15.3; 18.3 0.03 sig
SECONDARY
Successful Number of Vaginal and Cesarean Deliveries
41; 45; 15; 16 0.96
SECONDARY
Number of Participants Experiencing Tachysystole With Deceleration
10; 12
SECONDARY
Number of Participants With Post-partum Hemorrhage
2; 5
SECONDARY
Chorioamnionitis
5; 7
SECONDARY
Neonatal APGAR Scores
8; 8; 9; 9
SECONDARY
NICU Admission
0; 2
SECONDARY
Time to Complete Cervical Dilation
13.7; 17.1
SECONDARY
Delivery Within 24 Hours
49; 46
SECONDARY
Admission to NICU or Special Care Nursery
8; 11

Summary

The purpose of this study is to compare the efficacy of the combination of the supracervical foley bulb and vaginal misoprostol to vaginal misoprostol alone for labor induction. We hypothesize that use of the foley bulb plus vaginal misoprostol will result in shorter induction to delivery time.

Eligibility Criteria

Inclusion Criteria

  • singleton pregnancy
  • vertex presentation
  • unfavorable cervix(Bishop's score less than or equal to 6)
  • greater than 24 weeks gestation

Exclusion Criteria

  • fetal malpresentation
  • multifetal gestation
  • spontaneous labor
  • more than 5 uterine contractions in 10 minutes
  • contraindication to prostaglandins
  • non-reassuring fetal heart rate tracing
  • intrauterine growth restriction
  • anomalous fetus
  • fetal demise
  • previous cesarean delivery or other significant uterine surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01279343). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search